Stay updated on Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A sitewide NIH notice discusses the transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:26:02.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer now shows revision v3.7.1 instead of v3.7.0, while the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T20:00:34.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details with an access-denied notice and site footer.
    Difference
    20%
    Check dated 2026-09-22T21:51:57.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, signaling a new version of the page. The change is a backend version update and does not impact the displayed study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-09-15T22:13:06.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.6.6, replacing Revision: v3.6.5, indicating a platform revision update rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-09-01T19:27:26.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, indicating a new version of the page without changes to study content.
    Difference
    0.1%
    Check dated 2026-08-11T19:43:53.000Z thumbnail image

Stay in the know with updates to Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.